IP Verse

Novel Lipids And Compositions For The Delivery Of Therapeutics - EP4241767B1

PatentPatent Analysis

EP4241767

ARBUTUS BIOPHARMA
Application Number
EP23175192A
Filing Date
Nov 10, 2009
Status
Granted And Under Opposition
Sep 20, 2024
Grant Date
Oct 23, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2279254B1

Bibliography

The patent EP4241767B1 was granted to Arbutus Biopharma on Oct 23, 2024 following the initial filing on Nov 10, 2009 under the application number EP23175192A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ARROWHOUSEJul 23, 2025ADMISSIBLE
KELTIEJul 23, 2025ADMISSIBLE
MERCK SHARP & DOHME UKJul 23, 2025ADMISSIBLE
MODERNATXApr 29, 2025ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents